Centerspace (CSR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
18 Jan, 2026Executive summary
Q3 2024 core FFO was $1.18 per share, with stable revenue growth and expense control; core FFO for the nine months ended September 30, 2024, rose 3.4% year-over-year to $3.68 per share.
Revenue for Q3 2024 increased 0.7% year-over-year to $65.0 million, driven by higher same-store and non-same-store revenues, partially offset by property dispositions.
Net loss available to common shareholders was $6.2 million, or $(0.40) per diluted share, versus net income of $6.2 million, or $0.41 per diluted share, in Q3 2023.
Expanded Denver presence with The Lydian acquisition for $54.0 million, funded by assumed mortgage debt, OP units at a premium, and cash.
Raised $105 million via ATM share issuance, used to redeem all Series C preferred shares for $97.0 million and improve the balance sheet.
Financial highlights
Q3 2024 revenue: $65.0 million (+0.7% year-over-year); nine months: $194.6 million (-1.4% year-over-year).
Core FFO per diluted share: $1.18 for Q3 2024 (vs. $1.20 in Q3 2023); $3.68 for nine months (vs. $3.56 prior year).
Same-store revenue increased 3% year-over-year; same-store NOI up 2.8% in Q3 2024.
Weighted average occupancy for same-store properties: 95.3% in Q3 2024 (up from 94.6% in Q3 2023).
Distributions declared: $0.75 per common share for Q3 2024; $2.25 for nine months; annualized dividend per share was $3.00.
Outlook and guidance
2024 Core FFO per diluted share guidance raised to $4.82–$4.90, with same-store revenue growth expected at 3.0%–3.5% and NOI growth at 3.25%–3.75%.
Expense growth guidance lowered to 2.5%-3.25% for the year.
Recurring capital expenditures per home projected at $1,100–$1,150; value-add expenditures at $23–$25 million.
No additional acquisitions, dispositions, issuances, or borrowings factored into guidance post-Lydian.
Management is monitoring inflation, supply chain pressures, and capital market volatility for potential impacts.
Latest events from Centerspace
- Portfolio upgrades and market focus drive stable growth, strong retention, and financial resilience.CSR
Investor presentation27 Feb 2026 - 2025 saw robust NOI and profitability gains; 2026 outlook is stable with disciplined growth.CSR
Q4 202518 Feb 2026 - Q2 core FFO per share was $1.27, guidance raised, and liquidity remained robust.CSR
Q2 20242 Feb 2026 - Core FFO and NOI grew in 2024, with high occupancy and a positive 2025 outlook.CSR
Q4 202423 Dec 2025 - All proposals passed with strong support; trustees elected and board service recognized.CSR
AGM 202523 Dec 2025 - Shareholders will vote on trustees, executive pay, a new incentive plan, and auditor ratification.CSR
Proxy Filing1 Dec 2025 - Trustee elections, executive pay, incentive plan, and auditor ratification up for vote.CSR
Proxy Filing1 Dec 2025 - Vote sought on 2025 Incentive Plan; board recommends approval, impacting share reserves.CSR
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 4%, Core FFO $1.21/share, strong liquidity, and 2025 guidance reaffirmed.CSR
Q1 202528 Nov 2025